Covid-19 vaccine: Oxford University to start human trials from today
Oxford University will start human testing
with a Covid-19 vaccine they developed from Thursday, the UK
government said in a coronavirus press conference.
The
Oxford team – led by Professor Sarah Gilbert, is testing ChAdOx1 nCoV-19, a
candidate based on a chimpanzee adenovirus modified to include the spike or ‘S’
protein on the surface of SARS-CoV-2, the virus that causes Covid-19.
The
government funded the vaccine project with 20 million pounds to Oxford
University and another 22 million pounds to a second vaccine project at
Imperial College, London, Health Secretary Matt Hancock said on Wednesday,
adding the project will help support phase 2 trials and help prepare for a
larger phase 3 study. Read More
Comments
Post a Comment